Pura Vida Investments, LLC Immunovant, Inc. Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$13.08 - $49.6 $1.55 Million - $5.89 Million
-118,702 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$36.36 - $52.71 $1.47 Million - $2.13 Million
-40,324 Reduced 25.36%
118,702 $5.48 Million
Q3 2020

Nov 16, 2020
SELL
$22.61 - $38.9 $2.53 Million - $4.35 Million
-111,780 Reduced 41.28%
159,026 $5.6 Million
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $3.76 Million - $7.7 Million
270,806 New
270,806 $6.59 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email